Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% below average
Average (30q)
114.60%
Historical baseline
Range
High:2267.85%
Low:-100.00%
Volatility
2066.3%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | -100.00% |
| Q4 2023 | -100.00% |
| Q3 2023 | -31.65% |
| Q2 2023 | 80.42% |
| Q1 2023 | 1.50% |
| Q4 2022 | 771.84% |
| Q3 2022 | 11.28% |
| Q2 2022 | -85.77% |
| Q1 2022 | 2267.85% |
| Q4 2021 | -99.41% |
| Q3 2021 | -75.90% |
| Q2 2021 | -3.14% |
| Q1 2021 | 725.72% |
| Q4 2020 | 352.27% |
| Q3 2020 | -82.84% |
| Q2 2020 | -18.91% |
| Q1 2020 | 12.70% |
| Q4 2019 | 93.10% |
| Q3 2019 | -25.46% |
| Q2 2019 | -71.76% |
| Q1 2019 | -56.05% |
| Q4 2018 | 0.00% |
| Q1 2018 | -13.32% |
| Q4 2017 | 0.00% |
| Q1 2017 | 0.00% |